MedTrace Logo

755nm Alex Laser for Treatment of Stretch Marks

NCT01745211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-02-09

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of the bilateral treatment of striae using a 755nm Alexandrite laser.

Conditions

  • Striae

Interventions

DEVICE

755nm Alexandrite Laser

755nm Alexandrite laser with array handpiece

Sponsors & Collaborators

  • Cynosure, Inc.

    lead INDUSTRY

Principal Investigators

  • Patricia Krantz · Cynosure, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01745211 on ClinicalTrials.gov